EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 162 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $782 | +0.3% | 27,562 | +3.3% | 0.02% | 0.0% |
| Q4 2022 | $780 | -99.9% | 26,675 | +24.2% | 0.02% | +21.4% |
| Q3 2022 | $567,000 | -40.6% | 21,475 | 0.0% | 0.01% | -36.4% |
| Q2 2022 | $954,000 | -78.9% | 21,475 | -76.5% | 0.02% | -75.6% |
| Q1 2022 | $4,530,000 | -20.9% | 91,534 | -18.7% | 0.09% | -6.2% |
| Q4 2021 | $5,730,000 | -6.3% | 112,534 | +2.7% | 0.10% | -12.7% |
| Q3 2021 | $6,114,000 | +157.0% | 109,604 | +97.2% | 0.11% | +161.9% |
| Q2 2021 | $2,379,000 | – | 55,594 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |